← Evidence map

ArticleMolecular therapy. Oncology2026

A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanoma.

Daniel Stauber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41994560